Join our daily newsletter At The Bell to receive exclusive market insights
- Little Green Pharma (LGP) successfully imports its first shipment of cannabis flower medicines to Australia from its Danish facility
- This shipment consists of around 50 kilograms of LGP’s Flower THC 16 — Billy Buttons flower medicine
- Billy Buttons THC 16 has a THC content of 16 per cent and is available for sale in all Australian pharmacies in 15-gram packs
- Additionally, Little Green Pharma has appointed Morten Snede as Chief Financial Officer and Tony Roberts as General Manager EU
- Little Green Pharma is up 3.38 per cent on the market with shares trading at 76.5 cents at 2:07 pm AEST
Little Green Pharma (LGP) has successfully imported its first shipment of cannabis flower medicines to Australia from its Danish facility.
This shipment consists of around 50 kilograms of LGP’s Flower THC 16 — Billy Buttons flower medicine which is named after the Australian wildflower.
Billy Buttons THC 16 has a THC content of 16 per cent and is available for sale in all Australian pharmacies in 15-gram packs.
Little Green Pharma expects two additional shipments of its cannabis flower medicines by the end of October.
This shipment comes at a time when more Australian doctors become comfortable with administering dried flower medicine to their patients.
Managing Director Fleta Solomon is excited by this first shipment.
“The import of this first shipment so quickly following the acquisition is a milestone achievement by our new Denmark team,” Ms Solomon commented.
“To be able to meet all the regulatory requirements to supply and import product within this timeframe is a significant achievement and consistent with our reputation as a leading global medicinal cannabis business.”
Additionally, Little Green Pharma has appointed Morten Snede as Chief Financial Officer (CFO) and Tony Roberts as General Manager EU.
Mr Snede has over 20 years of experience in senior managerial positions across the financial and maritime industries, working as both CFO and Group Director.
Prior to joining Little Green Pharma, he was Managing Director at Canopy Growth.
Mr Roberts has over 34 years of experience in an Australian agribusiness with 20 years as a senior corporate executive in financial services, strategic planning, IT design and business acquisition.
He has previously worked as Managing Director of Tasmanian Botanics.
Little Green Pharma was up 3.38 per cent on the market with shares trading at 76.5 cents at 2:07 pm AEST.
